Artificial Intelligence as a Tool for Diagnosing and Monitoring Glaucoma

AI offers hope for easing the health-care burden in glaucoma.

By Meghana Kalavar, Sabita M. Ittoop, MD, MALIK KAHOOK, M.D.

A Stepwise Approach to Cases on the Angle-closure Spectrum

Treatment can prevent progression and vision loss.

By Ian Conner, MD, PhD

Detection of Apoptosing Retinal Cells Artificial Intelligence Technology in Glaucoma and AMD

This tool has promising applications in early detection.

By Radhika Pooja Patel, MBBS, BSc, DTMH, Paolo Corazza, MD, FEBO, Maria Francesca Cordeiro, MD, PhD

Prioritizing Quality of Life for Glaucoma Patients With Ab-interno Canaloplasty

The glaucoma treatment paradigm is shifting from long-term use of topical medications to restoring natural outflow.

By Mahmoud A. Khaimi, MD

Subconjunctival Glaucoma Devices

The number of choices is growing.

By Won I. Kim, MD

iTrack Effective in Standalone and Combination Procedures

By Jerry Helzner, contributing editor

Ivantis Releases 5-year Data on Hydrus Microstent

By Jerry Helzner, contributing editor

Patients Report iStent inject Improved Quality of Life

By Jerry Helzner, contributing editor

New World Medical Launches Goniotomy Tool

By Jerry Helzner, contributing editor

Iridex and Topcon Form Strategic Collaboration

By Jerry Helzner, contributing editor

COAST Trial to Assess Annual Low-energy SLT

By Jerry Helzner, contributing editor

OHTS 20-year Follow-up Data Published

By Jerry Helzner, contributing editor

European Glaucoma Society Accepts Laser as First-line Treatment

By Jerry Helzner, contributing editor

Review of iStent Devices in Standalone Procedures

By Jerry Helzner, contributing editor

AAO Identifies OCTA Role in Diagnosing OAG

By Jerry Helzner, contributing editor

New Genetic Links to Glaucoma Identified

By Jerry Helzner, contributing editor

Characteristics of First-appointment “No Shows”

By Jerry Helzner, contributing editor

Sight Sciences’ OMNI System Receives Expanded Indications

By Jerry Helzner, contributing editor

Endophthalmitis Associated With Glaucoma Drainage Implants

By Jerry Helzner, contributing editor

Drug-eluting Contact Lens Promising for Glaucoma

By Jerry Helzner, contributing editor

Early Phaco Deemed Most Effective for APAC

By Jerry Helzner, contributing editor

Wicks Have Mixed Results in Nonvalved Drainage Devices

By Jerry Helzner, contributing editor

Virtual Reality Perimeter Excels in Study

By Jerry Helzner, contributing editor

Fewer Serious Vision Problems for Older Americans

By Jerry Helzner, contributing editor

Normal-tension Glaucoma Linked to Dementia

By Jerry Helzner, contributing editor

Skye Bioscience Studies Synthetic Cannabinoid for Glaucoma

By Jerry Helzner, contributing editor

Citicoline Protects Against Glaucoma in Animal Study

By Jerry Helzner, contributing editor

Stem Cells Made Into Ganglion Cells

By Jerry Helzner, contributing editor

OCTA Artifacts Can Hinder Glaucoma Treatment

By Jerry Helzner, contributing editor

From the Editor: Glaucoma's Next Big Opportunity

By Nathan M. Radcliffe, MD

Product Spotlight: The First Digital SLT-YAG Platform Debuts

Device offers enhanced imaging capabilities and automatically integrates with EMRs.

By Karen Appold, contributing writer

Reversing Vision Loss With Neuromodulation

Numerous candidates could protect or restore vision after optic nerve injury.

By Julie Y. Cho, MD, PhD, Jeffrey L. Goldberg, MD, PhD

A Case of a Young Man With Angle Closure Glaucoma, Plateau Iris, and Pilocarpine Intolerance

Clear lens exchange and ECP/ECPL offer a new level of freedom.

By Brian A. Francis, MD, MS